Stock BTTX BETTER THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Better Therapeutics, Inc.

Equities

BTTX

US08773T1043

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 03:50:02 2024-04-19 pm EDT 		5-day change 1st Jan Change
0.0062 USD -22.50% Intraday chart for Better Therapeutics, Inc. -37.37% -96.82%
Mar. 21 Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc CI
Mar. 20 Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index CI

Business Summary

Better Therapeutics, Inc. is a prescription digital therapeutics (PDT) company. The Company is engaged in developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases. Its lead PDT product candidate, BT-001, is an investigational prescription digital therapy for the treatment of T2D. The investigational therapy is delivered via software that provides a tailored experience to patients designed to help them address the underlying causes of T2D by making meaningful, sustainable behavioral changes. The BT-001 investigational therapy is rooted in the well-studied, gold standard of behavioral modification therapies, cognitive behavioral therapy (CBT). The Company's platform consists of three behavioral therapy, treatment plans and personalization. Its behavioral therapy consists of lessons, skill- building modules, and a mechanism for goal setting. Its treatment plan is the primary engagement interface for patients.

Number of employees: 54

Managers

Managers TitleAgeSince
Andres Camacho CTO
 Chief Tech/Sci/R&D Officer - -
Leslie Miller AUD
 Comptroller/Controller/Auditor 43 21-09-30
Diane Gomez-Thinnes PRN
 Corporate Officer/Principal - 22-10-25
Thiago Licias de Oliveira HRO
 Human Resources Officer - 21-11-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 49,861,726 23,267,342 ( 46.66 %) 0 46.66 %

Shareholders

NameEquities%Valuation
David Perry
29.97 %
16,286,922 29.97 % 228 017 $
Kevin Appelbaum
4.428 %
2,406,719 4.428 % 33 694 $
Mountain Crest Capital LLC
2.554 %
1,388,250 2.554 % 19 436 $
Geoffrey Parker
1.996 %
1,085,138 1.996 % 15 192 $
Andrew Armanino
1.372 %
745,452 1.372 % 10 436 $
Frank Karbe
0.9687 %
526,516 0.9687 % 7 371 $
Mark Berman
0.8245 %
448,140 0.8245 % 6 274 $
MMCAP International Inc. SPC
0.6555 %
356,270 0.6555 % 4 988 $
Kristin Wynholds
0.4151 %
225,631 0.4151 % 3 159 $
Citadel Securities GP LLC
0.3977 %
216,165 0.3977 % 3 026 $

Company contact information

Better Therapeutics, Inc.

548 Market Street Suite 49404

94104, San Francisco

+

http://www.bettertx.com
address Better Therapeutics, Inc.(BTTX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.008 USD
Average target price
1.5 USD
Spread / Average Target
+18,650.00%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
BETTER THERAPEUTICS, INC. Stock Better Therapeutics, Inc.
-96.82% 436K
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.42% 41.35B
LONZA GROUP AG Stock Lonza Group AG
+42.15% 40.38B
MODERNA, INC. Stock Moderna, Inc.
+1.97% 39.05B
CELLTRION, INC. Stock Celltrion, Inc.
-14.19% 26.67B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+1.82% 24.07B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.55% 18.36B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-4.07% 11.68B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+21.36% 11.6B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+8.20% 11.15B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. BTTX Stock
  4. Company Better Therapeutics, Inc.